Chicago Partners Investment Group LLC Increases Stake in iShares Biotechnology ETF

In a recent filing with the Securities and Exchange Commission, Chicago Partners Investment Group LLC reported a 45.8% increase in its holdings of the iShares Biotechnology ETF (NASDAQ:IBB – Free Report) during the third quarter. This institutional investor now owns a total of 3,689 shares after acquiring an additional 1,159 shares within this timeframe. By the end of the latest reporting period, the value of Chicago Partners Investment Group LLC's investment in the iShares Biotechnology ETF was approximately $524,000.

Other significant investors have also adjusted their positions in the iShares Biotechnology ETF recently. Highline Wealth Partners LLC initiated a new position in the shares during the third quarter, worth around $30,000. Additionally, Bbjs Financial Advisors LLC opened a new position in the second quarter, valued at about $31,000. Voisard Asset Management Group Inc. acquired shares in the third quarter worth approximately $59,000, while Chris Bulman Inc. purchased shares in the second quarter for around $64,000. Finally, Eastern Bank also established a new position in the third quarter, valued at about $65,000. Together, hedge funds and other institutional investors own about 62.45% of the overall stock of the company.

Performance of iShares Biotechnology ETF

The iShares Biotechnology ETF's shares opened at $142.85 on a recent Tuesday. The fund's 50-day moving average stands at $145.02, and its 200-day moving average is $140.57. Over the past year, the ETF has experienced a low of $113.56 and a high of $150.57.

Dividend Information

In addition to these updates, the iShares Biotechnology ETF recently declared a dividend, which was distributed on Monday, September 30th. Shareholders on record as of Wednesday, September 25th received a dividend of $0.2005 per share, with the ex-dividend date also falling on September 25th.

About iShares Biotechnology ETF

The iShares Nasdaq Biotechnology ETF, formerly known as the iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF) designed to track the investment performance of the NASDAQ Biotechnology Index. This index comprises securities from NASDAQ-listed companies engaged in the biotechnology and pharmaceutical industries, which meet specific criteria set by NASDAQ.

investment, ETF, biotechnology